Document Detail


First in man use of the Advanta trademark V12 ePTFE-coated stent in aortic coarctation.
MedLine Citation:
PMID:  19530212     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The treatment of aortic coarctation has classically been surgery, but recent advances have seen the increasing adoption of percutaneous catheter based techniques to correct this problem. We describe a first in man use catheter technique with the Advanta ePTFE coated stent via a 9Fr access.
Authors:
Hafiz Hussein; Kevin Walsh
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  74     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-24     Completed Date:  2009-08-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  101-2     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Wiley-Liss, Inc.
Affiliation:
Beacon Hospital, Sandyford Industrial Estate, Dublin 18, Rep of Ireland. hafiz@me.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aortic Coarctation / radiography,  therapy*
Aortography / methods
Balloon Dilatation / instrumentation*
Humans
Male
Polytetrafluoroethylene*
Prosthesis Design
Stents*
Tomography, X-Ray Computed
Treatment Outcome
Chemical
Reg. No./Substance:
9002-84-0/Polytetrafluoroethylene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Commercial support of continuing medical education in the United States: the politics of doubt, the ...
Next Document:  A novel buddy balloon technique to recross a T-stented bifurcation.